PLoS One August 2016 PMID 26942907

Deprescribing in Frail Older People: A Randomised Controlled Trial.

Kathleen Potter, Leon Flicker, Amy Page, Christopher Etherton-Beer

Full text PDF Download social card

Mentions

Peak: 6 in Jun 2022

across 6 sources since Oct 2014

Extended reach

7,210

potential audience

Total likes

Video views

932

Mentions per month

Oct 2014 – May 2023

Where it's discussed

Facebook12 posts
X / Twitter9 posts
News5 articles
Reddit4 posts
YouTube2 videos
Blogs2 articles

AI synopsis

What people are saying

The overall sentiment shows general support for deprescribing, with posts emphasizing its safety and benefits, such as 'deprescribing is safe and beneficial' repeatedly. The tone remains positive and straightforward, reflecting moderate interest and engagement, primarily through sharing links and summarizing the study’s key findings without deep critique or broader implications.

AgreementStrong agreement

Most discussions reaffirm that deprescribing is safe and beneficial for older adults, citing the study’s positive outcomes and supporting its conclusions.

InterestModerate interest

There is moderate interest, as posts mention the clinical trial and its results but lack in-depth analysis or wider discussion.

EngagementModerate engagement

The discussions reflect some engagement through sharing study references and summarizing findings, but mostly remain surface-level.

ImpactModerate impact

The conversations suggest that the publication could influence attitudes towards deprescribing practices, though formal debates or policy implications are limited.

Abstract in brief

The study investigated whether deprescribing unnecessary medications could reduce polypharmacy in frail older adults living in aged care facilities, and found that it successfully decreased the average number of medicines taken.
Over a 12-month period, the group that underwent deprescribing discontinued about 78% of targeted medicines, leading to an average reduction of two medications per person, with no significant negative effects on other health outcomes.
Additionally, the deprescribing group had a lower mortality rate compared to the control group, suggesting potential survival benefits, though the study's small size and open design limit definitive conclusions.]

Read the full abstract

All mentions

Polypharmacy in Older Australians: Trends and Implications

This video discusses the prevalence of polypharmacy among Australians aged 70 and older, highlighting that in 2017, 36.1% were affected. As polypharmacy increases, so do concerns over the potential harm associated with…

Amy Page · Oct 14, 2014 921 views

Impact of Deprescribing on Older Adults' Health Outcomes

This video discusses the potential effects of deprescribing in older adults, focusing on its feasibility and impact on mortality and health. It reviews key findings from systematic research and meta-analysis aimed at…

Amy Page · May 12, 2022 11 views

Age Friendly

@Dakota_GWEP · X

Deprescribing inappropriate or redundant medications is safe and beneficial in older adults. doi:10.1371/journal.pone.0149984 https://t.co/CazBrVJhXh

May 10, 2023 · 148 followers View post →

Age Friendly

@Dakota_GWEP · X

Deprescribing inappropriate or redundant medications is safe and beneficial in older adults. doi:10.1371/journal.pone.0149984 https://t.co/jvmwqokrGe

Oct 1, 2022 · 2 likes · 148 followers View post →

US Deprescribing Research Network (USDeN)

@DeprescribeUS · X